Main Management ETF Advisors’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-36,650
Closed -$716K 138
2025
Q2
$716K Buy
36,650
+600
+2% +$10.7K 0.03% 116
2025
Q1
$640K Sell
36,050
-5,246
-13% -$113K 0.03% 112
2024
Q4
$884K Sell
41,296
-3,712
-8% -$90.3K 0.04% 77
2024
Q3
$1.41M Buy
+45,008
New +$1.12M 0.07% 46

Other funds holding CDNA

Main Management ETF Advisors's CDNA Position: Q3 2025 in Review

Main Management ETF Advisors sold out of CareDx (CDNA) in Q3 2025, closing a stake of 36,650 shares — an estimated $716K sold.

Main Management ETF Advisors first reported a position in CDNA in Q3 2024 and held it in 4 quarters. The position peaked at $1.41M in Q3 2024. 187 funds tracked by Wall St. Rank hold CDNA as of Q3 2025.

  • Main Management ETF Advisors reported no remaining CareDx position as of Q3 2025 after selling out during the quarter.
  • Main Management ETF Advisors sold 36,650 CareDx shares in Q3 2025, an estimated $716K.
  • Main Management ETF Advisors first reported a position in CareDx in Q3 2024 and held it in 4 quarters.
  • Main Management ETF Advisors's CareDx position peaked at $1.41M in Q3 2024.
  • 187 funds tracked by Wall St. Rank held CareDx as of Q3 2025.

Based on Main Management ETF Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.